TrimRx's Blog
Can Losing Weight on GLP-1s Improve Bladder Leakage? Stress Incontinence Explained
Yes, losing weight is one of the most reliably effective things you can do for stress urinary incontinence, and GLP-1 medications produce exactly the…
Does GLP-1 Weight Loss Improve Erectile Dysfunction? What Men Should Know
For many men, losing a significant amount of weight on a GLP-1 medication does improve erectile function, though the reason has more to do…
What Is Survodutide? The GLP-1/Glucagon Drug for Obesity and Liver Disease
Survodutide is an investigational once-weekly injectable from Boehringer Ingelheim and Zealand Pharma, being developed for both obesity and liver disease. It’s a dual agonist…
Orforglipron vs Ozempic: Pill vs Injection for Weight Loss
Orforglipron and Ozempic both harness GLP-1 to reduce appetite and drive weight loss, but they differ in two ways that matter day to day:…
What Is Orforglipron? The First Oral GLP-1 Pill for Weight Loss
Orforglipron, sold under the brand name Foundayo, is a once-daily GLP-1 pill for weight loss from Eli Lilly, and it reached a milestone in…
CagriSema vs Zepbound: What the Trial Data Suggests
CagriSema and Zepbound are two of the most powerful weight-loss approaches in obesity medicine, and on trial data they land in a broadly similar…
What Is CagriSema? Cagrilintide and Semaglutide Explained
CagriSema is an investigational once-weekly injectable from Novo Nordisk that combines two different weight-loss ingredients in one shot: cagrilintide, an amylin analog, and semaglutide,…
When Will Retatrutide Be Available? Timeline and What to Expect
If you’re waiting on retatrutide, here’s the realistic answer: it isn’t available yet, and based on Eli Lilly’s published trial timeline, an FDA submission…
What Is Retatrutide? The Triple-Agonist Obesity Drug Explained
Retatrutide is an investigational once-weekly injectable being developed by Eli Lilly for obesity, and in clinical trials it has produced the largest weight loss…
